Dietary Flavonoids: Effects on the Gene Expression And

Total Page:16

File Type:pdf, Size:1020Kb

Dietary Flavonoids: Effects on the Gene Expression And DIETARY FLAVONOIDS: EFFECTS ON THE GENE EXPRESSION AND ACTIVITY OF NQO1 A Project Presented to the Faculty of California State Polytechnic University, Pomona In Partial Fulfillment Of the Requirements for the Degree Master of Science In Nutrition and Food Science By Gianluis Pimentel-Barrantes 2020 SIGNATURE PAGE PROJECT: DIETARY FLAVONOIDS: EFFECTS ON THE GENE EXPRESSION AND ACTIVITY OF NQO1 AUTHOR: Gianluis Pimentel-Barrantes DATE SUBMITTED: Summer 2020 Department of Nutrition and Food Science Erik Froyen, Ph.D Project Committee Chair Nutrition and Food Science Valerie Mellano, Ph.D Plant Science Gabriel Davidov-Pardo, Ph.D Nutrition and Food Science ii ACKNOWLEDGEMENTS Foremost, I would like to thank Jesus, my God in heaven, for guiding me and giving me the strength to complete this project. I would not have been able to do it without Him. I would also like to express my sincere gratitude to my advisor Dr. Erik Froyen for the continuous support. Thank you for sharing your immense knowledge and for being a humble, motivational example. I would also like to thank the rest of my committee: Dr. Davidov-Pardo and Dr. Valerie Mellano for their encouragement, insightful comments, and patience throughout the process. I would like to thank my family, especially my brother Hector Alain for his continuous support throughout my studies. I would not have been able to do this without his support and I will always be grateful for what he has done for me. Finally, I want to thank my father Hector and my mother Marialuisa for supporting me to pursue an education in America and for being such a great example. iii ABSTRACT It is important to investigate which flavonoids are involved in the metabolism of xenobiotics to ameliorate the incidence of cancer around the world. Populations around the world are constantly exposed to a diversity of pollutants from the air, water, and soil. Substantial scientific evidence demonstrates that flavonoid-rich diets that are abundant in a diversity of fruits and vegetables can protect eukaryotic cells from oxidative stress. It has been found that multiple flavonoids from various subclasses such as anthocyanidins (anthocyanin, cyanidin, pelargonidin, kuromanin, delphinidin, malvidin), flavan-3-ols (epigallocatechin gallate, catechin), flavonols (quercetin, kaempferol, galangin, isorhamnetin, myricetin, morin, taxifolin, hyperoside, rutin), flavones (apigenin, diosmetin, luteolin, scutellarin, rutin, 4’dimethylnobiletin), and isoflavones (genistein, daidzein, equol, biochanin A, cuomestrol, tectorigenin, glycitein) can modulate quinone reductase (QR) activity and mRNA expression in cell and animal studies and therefore increase the excretion of carcinogens. Although, more research needs to be done on the mechanisms by which flavonoids induce QR to be able to provide precise dietary recommendations of flavonoids to humans. This paper presents the current knowledge of single isolated flavonoids and their roles in xenobiotic metabolism. iv TABLE OF CONTENTS SIGNATURE PAGE........................................................................................................... ii ACKNOWLEDGMENTS ................................................................................................. iii ABSTRACT....................................................................................................................... iv CHAPTER 1: Introduction ................................................................................................. 1 CHAPTER 2: Methodology................................................................................................ 5 CHAPTER 3: Results ......................................................................................................... 6 CHAPTER 4: Discussion.................................................................................................. 10 CHAPTER 5: Conclusion................................................................................................. 19 REFERENCES ................................................................................................................. 20 APPENDIX: Tables & Figures......................................................................................... 33 v CHAPTER 1: Introduction The prevalence of cancer is among the leading causes of death worldwide, and the number of cases per year is expected to rise to 23.6 million by 2030. National Cancer Institute (2018) explained the incidence of cancer has become a burden to the American society, as it was estimated that in 2018 a total of 1,735,350 new cases were diagnosed. The estimated national expenditure for cancer care has dramatically increased over the years, as in 2017 in the United States $147.3 billion were spent. Multiple epidemiological studies have suggested that diets rich in fruits and vegetables may protect humans from developing chronic diseases such as cancer, cardiovascular disease, and diabetes. Studies have demonstrated that certain phytochemicals which are abundant in plants, can induce the expression of the phase II enzymes in the liver responsible for xenobiotic metabolism (Dinkova-Kostova et al., 2004). The process of xenobiotic metabolism consists of enzymatic reactions which transforms chemicals such as carcinogens and drugs into forms readily for excretion (Ierapetritou et al., 2009). It is crucial to understand the pharmacological roles of phytochemicals in xenobiotic metabolism, as humans today are exposed to a vast diversity of contaminants (Barradas-Gimate et al., 2017). Electrophiles and oxidants such as quinone metabolites, are ubiquitous in aerobic organisms such as plants and mammals as a result from metabolic processes and xenobiotic metabolism (Raymond & Segre, 2006). However, exogenous sources of quinone metabolites can also be derived from the burning of fossil fuels which generate the polycyclic aromatic hydrocarbons (PAHs), the intake of drugs, exposure to pesticides and other similar activities commonly seen in industrialized nations (Monks & Jones, 2002). For instance, α- and β-unsaturated aldehydes byproducts from lipid peroxidation 1 and industrial processes are harmful electrophiles that have the capacity to promote cellular oxidative stress; thus, disrupting DNA, proteins, and plasma membranes (Bossy- Wetzel et al., 2004). A large body of evidence reviewed in Braeuning et al. (2006) confirms that frequent cellular exposure to free radicals, promotes the synthesis of reactive oxygen species that facilitate the development of chronic diseases such as different types of cancers, cardio vascular disease, atherosclerosis, chronic inflammatory disease, faster aging, and neurodegenerative conditions like Alzheimer’s disease. The National Toxicology Program from the U.S. Department of Health and Human Services has reported a list of 248 harmful substances that promote toxicity and development of cancer in humans based on the available scientific evidence. Common examples include PAHs, halogenated aromatic hydrocarbons, and heterocyclic amines (Nebert et al., 2004). The major source of heterocyclic amines in the United States comes from barbeque meats, as amino acids are converted into these products from cooking meats under high temperatures (Froyen EB, 2016; Sinha et al., 1998). Recent studies have demonstrated that a diversity of compounds such as phytochemicals, endogenous chemicals, therapeutics, environmental agents, and exogenous chemicals (electrophiles) modulate the ARE/EpRE gene involved in the transcription of phase II enzymes (Dinkova-Kostova et al., 2004). For instance, some of the hydroxylated flavonoids ubiquitously found in plants, have been noted to modulate cell signaling cascades. However, among the 12 subclasses of flavonoids, only 6 have been marked of dietary significance which are anthocyanidins, flavan-3-ols, flavonols, flavones, flavanones, and isoflavones (Table 1 & Figure 1) (Higdon et al., 2016). Studies have shown that the activation of electrophile-responsive element (ARE/EpRE) may 2 occur via electrophiles and other compounds at the promoter region (Lee & Surh, 2005). The activation of EpRE occurs via the family of transcription factors nuclear factor erythroid 2–related factor 2 (Nrf2) binding to EpRE. The transcription factor Nrf2 is a member of the cap ‘n’ collar subfamily of basic region leucine zipper transcription factors which are in the cytosol under resting conditions (Moi et al., 1994). When Nrf2 is found in the cytosol is normally bound to the cytoskeleton-bound Kelch-like erythroid cell-derived protein with cap ‘n’ collar homology–associated protein 1 (Keap1) (Zhang et al., 2009). The entry of environmental carcinogens or phytochemicals into the cytosol, promotes the dissociation between Nrf2 and Keap1, allowing the Nrf2 to translocate into the nucleus to promote the transcription of phase II enzymes (Nguyen et al., 2004; Kobayashi & Yamamoto, 2005). Nrf2 has been identified to mediate the induction of phase II enzymes such as: NADPH-dependent quinone oxidoreductase-1 (NQO1), heme-oxygenase 1 heat shock protein 32 (HO-1), glutathione-S-transferase (GST), DP-glucuronosyltransferase 1A6, and sulfurotransferases (Aleksunes et al., 2006; Itoh et al., 1997). In addition, different kinases enzymes are involved in the activation of Nrf2, such as mitogen-activated protein kinase (MAPK), protein kinase C, and phosphatidylinositol 3-kinase (PI3K) (Eggler et al., 2008). The MAPK family of kinases includes the JNK, ERK, and p38 which are regulators of downstream transcription factors
Recommended publications
  • Graphical Abstract CG 18-1-MS
    Send Orders for Reprints to [email protected] 3 Current Genomics, 2017, 18, 3-26 REVIEW ARTICLE ISSN: 1389-2029 eISSN: 1875-5488 Impact Factor: 2.43 Established Human Cell Lines as Models to Study Anti-leukemic Effects of Flavonoids BENTHAM SCIENCE Katrin Sak* and Hele Everaus Department of Hematology and Oncology, University of Tartu, Tartu, Estonia Abstract: Despite the extensive work on pathological mechanisms and some recent advances in the treatment of different hematological malignancies, leukemia continues to present a significant challenge being frequently considered as incurable disease. Therefore, the development of novel therapeutic agents with high efficacy and low toxicity is urgently needed to improve the overall survival rate of pa- A R T I C L E H I S T O R Y tients. In this comprehensive review article, the current knowledge about the anticancer activities of Received: May 11, 2015 flavonoids as plant secondary polyphenolic metabolites in the most commonly used human established Revised: November 20, 2015 Accepted: November 27, 2015 leukemia cell lines (HL-60, NB4, KG1a, U937, THP-1, K562, Jurkat, CCRF- CEM, MOLT-3, and MOLT-4) is compiled, revealing clear anti-proliferative, pro-apoptotic, cell cycle arresting, and differ- DOI: 10.2174/138920291766616080316 entiation inducing effects for certain compounds. Considering the low toxicity of these substances in 5447 normal blood cells, the presented data show a great potential of flavonoids to be developed into novel anti-leukemia agents applicable also in the malignant cells resistant to the current conventional che- motherapeutic drugs. Keywords: Antiproliferation, Apoptosis, Cell cycle arrest, Cytotoxicity, Differentiation, Flavonoids, Leukemia, Human cell lines.
    [Show full text]
  • Cytotoxic Activities of Flavonoids from Centaurea Scoparia
    Hindawi Publishing Corporation e Scientific World Journal Volume 2014, Article ID 274207, 7 pages http://dx.doi.org/10.1155/2014/274207 Research Article Cytotoxic Activities of Flavonoids from Centaurea scoparia Sayed A. Ahmed and Emadeldin M. Kamel Chemistry Department, Faculty of Science, Beni Suef University, Salah Salem Street, P.O. Box 62514, Beni Suef 62514, Egypt Correspondence should be addressed to Sayed A. Ahmed; [email protected] Received 17 January 2014; Accepted 22 May 2014; Published 11 June 2014 Academic Editor: Diego Savoia Copyright © 2014 S. A. Ahmed and E. M. Kamel. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Phytochemical studies on the ethanolic extract of the aerial parts of Centaurea scoparia ledtotheisolationof two new flavonoids, 3 ,4 -dihydroxy-(3 ,4 -dihydro-3 -hydroxy-4 -acetoxy)-2 ,2 -dimethylpyrano-(5 ,6 :7,8)-flavone-3-O-- D-glucopyranoside (1)and3,3,4 -trihydroxy-(3 ,4 -dihydro-3 ,4 -dihydroxy)-2 ,2 -dimethylpyrano-(5 ,6 :7,8)-flavone (2), along with eight known flavonoids isolated for the first time from this plant, cynaroside (3), Apigetrin (4), centaureidin (5), oroxylin A(6), 5,7-dihydroxy-3 ,4 ,5 -trimethoxyflavone (7), atalantoflavone (8), 5-hydroxy-3 ,4 ,8-trimethoxy-2 ,2 -dimethylpyrano (5 ,6 :6,7)-flavone (9), and 3 ,4 ,5,8-tetramethoxy-2 ,2 -dimethylpyrano (5 ,6 :6,7)-flavone (10). The structures of the isolated compounds were elucidated by means of spectroscopic tools including 1D and 2D NMR, UV,IR, and mass spectroscopy.
    [Show full text]
  • The Phytochemistry of Cherokee Aromatic Medicinal Plants
    medicines Review The Phytochemistry of Cherokee Aromatic Medicinal Plants William N. Setzer 1,2 1 Department of Chemistry, University of Alabama in Huntsville, Huntsville, AL 35899, USA; [email protected]; Tel.: +1-256-824-6519 2 Aromatic Plant Research Center, 230 N 1200 E, Suite 102, Lehi, UT 84043, USA Received: 25 October 2018; Accepted: 8 November 2018; Published: 12 November 2018 Abstract: Background: Native Americans have had a rich ethnobotanical heritage for treating diseases, ailments, and injuries. Cherokee traditional medicine has provided numerous aromatic and medicinal plants that not only were used by the Cherokee people, but were also adopted for use by European settlers in North America. Methods: The aim of this review was to examine the Cherokee ethnobotanical literature and the published phytochemical investigations on Cherokee medicinal plants and to correlate phytochemical constituents with traditional uses and biological activities. Results: Several Cherokee medicinal plants are still in use today as herbal medicines, including, for example, yarrow (Achillea millefolium), black cohosh (Cimicifuga racemosa), American ginseng (Panax quinquefolius), and blue skullcap (Scutellaria lateriflora). This review presents a summary of the traditional uses, phytochemical constituents, and biological activities of Cherokee aromatic and medicinal plants. Conclusions: The list is not complete, however, as there is still much work needed in phytochemical investigation and pharmacological evaluation of many traditional herbal medicines. Keywords: Cherokee; Native American; traditional herbal medicine; chemical constituents; pharmacology 1. Introduction Natural products have been an important source of medicinal agents throughout history and modern medicine continues to rely on traditional knowledge for treatment of human maladies [1]. Traditional medicines such as Traditional Chinese Medicine [2], Ayurvedic [3], and medicinal plants from Latin America [4] have proven to be rich resources of biologically active compounds and potential new drugs.
    [Show full text]
  • WO 2012/159639 Al 29 November 2012 (29.11.2012)
    (12) INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (19) World Intellectual Property Organization International Bureau (10) International Publication Number (43) International Publication Date WO 2012/159639 Al 29 November 2012 (29.11.2012) (51) International Patent Classification: AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, A23L 1/30 (2006.01) A61K 36/48 (2006.01) CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, A61K 36/185 (2006.01) A61K 36/8962 (2006.01) DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, A61K 36/63 (2006.01) A61K 36/54 (2006.01) HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, A61K 36/23 (2006.01) A61K 36/71 (2006.01) KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, A61K 36/9066 (2006.01) A61K 36/886 (2006.01) MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, A61K 36/28 (2006.01) A61K 36/53 (2006.01) OM, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SC, SD, A61K 36/82 (2006.01) A61K 36/64 (2006.01) SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, A61K 36/67 (2006.01) TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW. (21) International Application Number: (84) Designated States (unless otherwise indicated, for every PCT/EG20 12/0000 18 kind of regional protection available): ARIPO (BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, SZ, TZ, (22) International Filing Date: UG, ZM, ZW), Eurasian (AM, AZ, BY, KG, KZ, RU, TJ, 22 May 2012 (22.05.2012) TM), European (AL, AT, BE, BG, CH, CY, CZ, DE, DK, (25) Filing Language: English EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, (26) Publication Language: English TR), OAPI (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, (30) Priority Data: ML, MR, NE, SN, TD, TG).
    [Show full text]
  • Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns
    molecules Review Dietary Flavonoids: Cardioprotective Potential with Antioxidant Effects and Their Pharmacokinetic, Toxicological and Therapeutic Concerns Johra Khan 1,†, Prashanta Kumar Deb 2,3,†, Somi Priya 4 , Karla Damián Medina 5, Rajlakshmi Devi 2, Sanjay G. Walode 6 and Mithun Rudrapal 6,*,† 1 Department of Medical Laboratory Sciences, College of Applied Medical Sciences, Majmaah University, Al Majmaah 11952, Saudi Arabia; [email protected] 2 Life Sciences Division, Institute of Advanced Study in Science and Technology, Guwahati 781035, Assam, India; [email protected] (P.K.D.); [email protected] (R.D.) 3 Department of Pharmaceutical Sciences & Technology, Birla Institute of Technology, Mesra, Ranchi 835215, Jharkhand, India 4 University Institute of Pharmaceutical Sciences, Panjab University, Chandigarh 160014, India; [email protected] 5 Food Technology Unit, Centre for Research and Assistance in Technology and Design of Jalisco State A.C., Camino Arenero 1227, El Bajío del Arenal, Zapopan 45019, Jalisco, Mexico; [email protected] 6 Rasiklal M. Dhariwal Institute of Pharmaceutical Education & Research, Chinchwad, Pune 411019, Maharashtra, India; [email protected] * Correspondence: [email protected]; Tel.: +91-8638724949 † These authors contributed equally to this work. Citation: Khan, J.; Deb, P.K.; Priya, S.; Medina, K.D.; Devi, R.; Walode, S.G.; Abstract: Flavonoids comprise a large group of structurally diverse polyphenolic compounds of Rudrapal, M. Dietary Flavonoids: plant origin and are abundantly found in human diet such as fruits, vegetables, grains, tea, dairy Cardioprotective Potential with products, red wine, etc. Major classes of flavonoids include flavonols, flavones, flavanones, flavanols, Antioxidant Effects and Their anthocyanidins, isoflavones, and chalcones. Owing to their potential health benefits and medicinal Pharmacokinetic, Toxicological and significance, flavonoids are now considered as an indispensable component in a variety of medicinal, Therapeutic Concerns.
    [Show full text]
  • Flavonoids As an Intervention for Alzheimer's Disease
    Brain Plasticity 6 (2020) 167–192 167 DOI 10.3233/BPL-200098 IOS Press Review Flavonoids as an Intervention for Alzheimer’s Disease: Progress and Hurdles Towards Defining a Mechanism of Action Katriona L. Hole and Robert J. Williams* Centre for Regenerative Medicine, Department of Biology and Biochemistry, University of Bath, UK Abstract. Attempts to develop a disease modifying intervention for Alzheimer’s disease (AD) through targeting amyloid ␤ (A␤) have so far been unsuccessful. There is, therefore, a need for novel therapeutics against alternative targets coupled with approaches which may be suitable for early and sustained use likely required for AD prevention. Numerous in vitro and in vivo studies have shown that flavonoids can act within processes and pathways relevant to AD, such as A␤ and tau pathology, increases in BDNF, inflammation, oxidative stress and neurogenesis. However, the therapeutic development of flavonoids has been hindered by an ongoing lack of clear mechanistic data that fully takes into consideration metabolism and bioavailability of flavonoids in vivo. With a focus on studies that incorporate these considerations into their experimental design, this review will evaluate the evidence for developing specific flavonoids as therapeutics for AD. Given the current lack of success of anti-A␤ targeting therapeutics, particular attention will be given to flavonoid-mediated regulation of tau phosphorylation and aggregation, where there is a comparable lack of study. Reflecting on this evidence, the obstacles that prevent therapeutic development of flavonoids will be examined. Finally, the significance of recent advances in flavonoid metabolomics, modifications and influence of the microbiome on the therapeutic capacity of flavonoids in AD are explored.
    [Show full text]
  • Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin
    Review Potential Role of Flavonoids in Treating Chronic Inflammatory Diseases with a Special Focus on the Anti-Inflammatory Activity of Apigenin Rashida Ginwala, Raina Bhavsar, DeGaulle I. Chigbu, Pooja Jain and Zafar K. Khan * Department of Microbiology and Immunology, and Center for Molecular Virology and Neuroimmunology, Center for Cancer Biology, Institute for Molecular Medicine and Infectious Disease, Drexel University College of Medicine, Philadelphia, PA 19129, USA; [email protected] (R.G.); [email protected] (R.B.); [email protected] (D.I.C.); [email protected] (P.J.) * Correspondence: [email protected] Received: 28 November 2018; Accepted: 30 January 2019; Published: 5 February 2019 Abstract: Inflammation has been reported to be intimately linked to the development or worsening of several non-infectious diseases. A number of chronic conditions such as cancer, diabetes, cardiovascular disorders, autoimmune diseases, and neurodegenerative disorders emerge as a result of tissue injury and genomic changes induced by constant low-grade inflammation in and around the affected tissue or organ. The existing therapies for most of these chronic conditions sometimes leave more debilitating effects than the disease itself, warranting the advent of safer, less toxic, and more cost-effective therapeutic alternatives for the patients. For centuries, flavonoids and their preparations have been used to treat various human illnesses, and their continual use has persevered throughout the ages. This review focuses on the anti-inflammatory actions of flavonoids against chronic illnesses such as cancer, diabetes, cardiovascular diseases, and neuroinflammation with a special focus on apigenin, a relatively less toxic and non-mutagenic flavonoid with remarkable pharmacodynamics. Additionally, inflammation in the central nervous system (CNS) due to diseases such as multiple sclerosis (MS) gives ready access to circulating lymphocytes, monocytes/macrophages, and dendritic cells (DCs), causing edema, further inflammation, and demyelination.
    [Show full text]
  • Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells in Vivo and in Vitro by Activating the Mitochondrial Pathway
    Hindawi Evidence-Based Complementary and Alternative Medicine Volume 2021, Article ID 9922059, 13 pages https://doi.org/10.1155/2021/9922059 Research Article Huxie Huaji Ointment Induced Apoptosis of Liver Cancer Cells In Vivo and In Vitro by Activating the Mitochondrial Pathway Yuan Cai ,1 Qing Du ,1 Tian-Hao Deng ,1 Bing-Bing Shen ,1 Yan-Mei Peng ,1 Pu-Hua Zeng ,1 and Song-Ren Yu 2 1Institute of Traditional Chinese Medicine, Hunan Academy of Chinese Medicine, Changsha 410006, China 2Jiangxi University of Chinese Medicine, Nanchang, Jiangxi 330006, China Correspondence should be addressed to Pu-Hua Zeng; [email protected] and Song-Ren Yu; [email protected] Received 9 March 2021; Revised 28 May 2021; Accepted 6 July 2021; Published 15 July 2021 Academic Editor: Yu CAI Copyright © 2021 Yuan Cai et al. 0is is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Huxie Huaji (HXHJ) Ointment is a famous traditional Chinese medicinal prescription and is commonly used for the clinical treatment of hepatocellular carcinoma by boosting immunity and detoxification. However, the scientific evidence for the effect of HXHJ Ointment on hepatocellular carcinoma and the underlying molecular mechanism are lacking. 0e present study aimed to identify the effects of HXHJ Ointment on hepatocellular carcinoma in vitro and in vivo as well as investigating the mechanistic basis for the anticancer effect of HXHJ ointment. First, liquid chromatography-mass spectrometry was used to verify the composition of HXHJ Ointment and quality control.
    [Show full text]
  • Inhibitory Effects Against Α-Glucosidase and Α-Amylase of The
    Li et al. Chemistry Central Journal (2018) 12:82 https://doi.org/10.1186/s13065-018-0445-y RESEARCH ARTICLE Open Access Inhibitory efects against α‑glucosidase and α‑amylase of the favonoids‑rich extract from Scutellaria baicalensis shoots and interpretation of structure–activity relationship of its eight favonoids by a refned assign‑score method Ke Li, Fan Yao, Qiang Xue, Hang Fan, Lingguang Yang, Xiang Li, Liwei Sun and Yujun Liu* Abstract A favonoids-rich extract of Scutellaria baicalensis shoots and its eight high content favonoids were investigated for their inhibitory efects against α-glucosidase and α-amylase. Results show that abilities of the extract in inhibiting the two enzymes were obviously higher than those of acarbose. Moreover, inhibitory abilities of all the eight individual favonoids against the two enzymes show exactly a same order (i.e., apigenin > baicalein > scutellarin > chrysin > api- genin-7-O-glucuronide > baicalin > chrysin-7-O-glucuronide > isocarthamidin-7-O-glucuronide), and their structure– activity relationship could be well-interpretated by the refned assign-score method. Furthermore, based on the inhibitory abilities and their contents in the extract, it was found that the eight favonoids made predominant contri- butions, among which baicalein and scutellarin played roles as preliminary contributors, to overall inhibitory efects of the extract against the two enzymes. Beyond these, contributions of the eight favonoids to the overall enzyme inhibitory activity were compared with those to the overall antioxidant
    [Show full text]
  • Flavonoids from Artemisia Annua L. As Antioxidants and Their Potential Synergism with Artemisinin Against Malaria and Cancer
    Molecules 2010, 15, 3135-3170; doi:10.3390/molecules15053135 OPEN ACCESS molecules ISSN 1420-3049 www.mdpi.com/journal/molecules Review Flavonoids from Artemisia annua L. as Antioxidants and Their Potential Synergism with Artemisinin against Malaria and Cancer 1, 2 3 4 Jorge F.S. Ferreira *, Devanand L. Luthria , Tomikazu Sasaki and Arne Heyerick 1 USDA-ARS, Appalachian Farming Systems Research Center, 1224 Airport Rd., Beaver, WV 25813, USA 2 USDA-ARS, Food Composition and Methods Development Lab, 10300 Baltimore Ave,. Bldg 161 BARC-East, Beltsville, MD 20705-2350, USA; E-Mail: [email protected] (D.L.L.) 3 Department of Chemistry, Box 351700, University of Washington, Seattle, WA 98195-1700, USA; E-Mail: [email protected] (T.S.) 4 Laboratory of Pharmacognosy and Phytochemistry, Ghent University, Harelbekestraat 72, B-9000 Ghent, Belgium; E-Mail: [email protected] (A.H.) * Author to whom correspondence should be addressed; E-Mail: [email protected]. Received: 26 January 2010; in revised form: 8 April 2010 / Accepted: 19 April 2010 / Published: 29 April 2010 Abstract: Artemisia annua is currently the only commercial source of the sesquiterpene lactone artemisinin. Since artemisinin was discovered as the active component of A. annua in early 1970s, hundreds of papers have focused on the anti-parasitic effects of artemisinin and its semi-synthetic analogs dihydroartemisinin, artemether, arteether, and artesunate. Artemisinin per se has not been used in mainstream clinical practice due to its poor bioavailability when compared to its analogs. In the past decade, the work with artemisinin-based compounds has expanded to their anti-cancer properties.
    [Show full text]
  • Flavonoids: Structure–Function and Mechanisms of Action and Opportunities for Drug Development
    Toxicological Research Toxicol Res. eISSN 2234-2753 https://doi.org/10.1007/s43188-020-00080-z pISSN 1976-8257 INVITED REVIEW Flavonoids: structure–function and mechanisms of action and opportunities for drug development Stephen Safe1 · Arul Jayaraman2 · Robert S. Chapkin3 · Marcell Howard1 · Kumaravel Mohankumar1 · Rupesh Shrestha4 Received: 10 November 2020 / Accepted: 4 December 2020 © Korean Society of Toxicology 2021 Abstract Flavonoids are polyphenolic phytochemicals produced in fruits, nuts and vegetables and dietary consumption of these structurally diverse compounds is associated with multiple health benefts including increased lifespan, decreased cardio- vascular problems and low rates of metabolic diseases. Preclinical studies with individual favonoids demonstrate that these compounds exhibit anti-infammatory and anticancer activities and they enhance the immune system. Their efectiveness in both chemoprevention and chemotherapy is associated with their targeting of multiple genes/pathways including nuclear receptors, the aryl hydrocarbon receptor (AhR), kinases, receptor tyrosine kinases and G protein-coupled receptors. However, despite the remarkable preclinical activities of favonoids, their clinical applications have been limited and this is due, in part, to problems in drug delivery and poor bioavailability and these problems are being addressed. Further improvements that will expand clinical applications of favonoids include mechanism-based precision medicine approaches which will identify critical mechanisms of action
    [Show full text]
  • Organ-Specific Metabolic Shifts of Flavonoids in Scutellaria
    molecules Article Organ-Specific Metabolic Shifts of Flavonoids in Scutellaria baicalensis at Different Growth and Development Stages Jingyuan Xu ID , Yilan Yu, Ruoyun Shi, Guoyong Xie, Yan Zhu, Gang Wu and Minjian Qin * ID Department of Resources Science of Traditional Chinese Medicines, School of Traditional Chinese Pharmacy and State Key Laboratory of Natural Medicines, China Pharmaceutical University, Nanjing 210009, China; [email protected] (J.X.); [email protected] (Y.Y.); [email protected] (R.S.); [email protected] (G.X.); [email protected] (Y.Z.); [email protected] (G.W.) * Correspondence: [email protected]; Tel.: +86-025-8618-5130 Received: 24 January 2018; Accepted: 14 February 2018; Published: 15 February 2018 Abstract: Scutellaria baicalensis Georgi is a traditional Chinese herbal medicine mainly containing flavonoids that contribute to its bioactivities. In this study, the distributions and dynamic changes of flavonoid levels in various organs of S. baicalensis at different development stages were investigated by UHPLC-QTOF-MS/MS and HPLC-DAD methods. The results indicated that the metabolic profiles of S. baicalensis changed with growth and development. During the initial germination stage, the seeds mainly contained flavonols. With growth, the main kinds of flavonoids in S. baicalensis changed from flavonols to flavanones and flavones. The results also revealed that the accumulation of flavonoids in S. baicalensis is organ-specific. The flavones without 40-OH groups mainly accumulate in the root and the flavanones mainly accumulate in aerial organs. Dynamic accumulation analysis showed that the main flavonoids in the root of S. baicalensis accumulated rapidly before the full-bloom stage, then changed to a small extent.
    [Show full text]